In the present study, we demonstrated for the first time that RES reversed DOX‐resistance, inhibited migration capacity of breast cancer DOX‐resistant cells by modulating EMT phenotype and SIRT1/β‐catenin pathway. Here, SIRT1 is linked to breast carcinoma.